NIH-funded research R01 grant

Investigating cognitive impairment caused by prostate cancer treatment in rats

Official title: Therapy-induced cognitive impairment in a rat model of prostate cancer

Funded at University of Texas Hlth Science Center · NIH-10868648 · Data updated 2026-11-12

This study is looking at how a common prostate cancer treatment called androgen deprivation therapy might affect thinking and memory, and it will also test if an antidepressant can help improve these issues.

More Prostate Cancer research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Texas Hlth Science Center
NIH-funded
Lab location1 site (San Antonio, United States)
Project startAugust 1, 2023
Project endJuly 31, 2028
Funding year2024
Award (this year)$390,969
NIH project number5R01CA285183-02
Project IDNIH-10868648 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are prostate cancer patients who are undergoing or have undergone androgen deprivation therapy.

Less likely to help

Patients who are not receiving androgen deprivation therapy or those with advanced dementia may not benefit from this research.

What this research studies

This research explores how androgen deprivation therapy (ADT), a common treatment for prostate cancer, affects cognitive functions such as memory and executive function. Using a rat model, the study will examine the structural and functional changes in the brain caused by ADT and how these changes may lead to cognitive impairment. The researchers will also investigate the potential of vortioxetine, an antidepressant, to alleviate these cognitive deficits. By introducing cancer pathophysiology into the model, the study aims to better understand the interplay between cancer treatment and cognitive health.

Why it matters

Potential benefit: If successful, this research could lead to improved strategies for mitigating cognitive impairment in prostate cancer survivors undergoing ADT.

How similar studies have gone: Previous studies have shown that cognitive impairments related to cancer treatments can be mitigated by certain interventions, suggesting potential for success in this approach.

Where this research is happening

  • University of Texas Hlth Science Center
    San Antonio, United States
    Active

Researchers

  • Principal investigator: Morilak, David a — University of Texas Hlth Science Center
  • Study coordinator: Morilak, David a

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.